The American College of Surgeons’ Commission on Cancer recently presented an Outstanding Achievement Award to the Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai.

Cedars-Sinai’s Samuel Oschin Comprehensive Cancer Institute was one of 32 programs nationwide to be recognized by the American College of Surgeons’ Commission on Cancer. (photo courtesy of Cedars-Sinai Medical Center)

The institute is one of only 32 accredited cancer programs in the United States to receive the award; only seven percent of programs surveyed by the commission receive the honor. Recipients were judged on qualitative and quantitative surveys of cancer programs conducted during the second half of 2017.

“This award demonstrates the continuing efforts by Cedars-Sinai to offer cancer patients the best multidisciplinary care,” said Dr. Robert A. Figlin, deputy director of the Samuel Oschin Comprehensive Cancer Institute. “That care addresses the patient and their family and relies on the strongest science-based evidence to support the best possible health outcomes.”

The commission evaluated the institute on 34 program standards, including data management, clinical services and quality improvement during two survey visits conducted during the second half of 2017, said Figlin, who is also director of the Cancer Institute’s Division of Hematology/Oncology.

The award increases awareness about care choices, said Dr. Lawrence N. Shulman, chair of the commission.

“More and more, we’re finding that patients and their families want to know how the healthcare institutions in their communities compare with one another,” Shulman said.

For information, visit cedars-sinai.org.